Evaluation of the synthetic osmotic dilator (Dilapan-S®) for induction of labour through a multicentre retrospective registry of real-world data in the United Kingdom.

Introduction: In 2015, Dilapan-S was approved by the FDA for cervical ripening in pregnancy. This synthetic hygroscopic agent for labour induction has increased the options for initiating labour. This real-world evaluation aims to determine if Dilapan